Publication date: Oct 01, 2024
We report a case of persistent lupus anticoagulant (LAC) positivity following mild COVID-19 in a 64-year-old Japanese male with a history of atrial fibrillation. The patient experienced post-COVID-19 condition symptoms, including intermittent fatigue, taste disturbance, and persistent numbness in the upper arm, persistently for over 10 months. Laboratory investigations revealed prolonged activated partial thromboplastin time (aPTT) of 70. 0 seconds, positive LAC of 1. 5, and positive anti-cardiolipin-beta2-glycoprotein I complex antibody of 4. 3 U/mL. This case highlights the potential for long-term LAC positivity after mild COVID-19 and raises questions about its association with post-COVID-19 conditions. The persistence of LAC positivity is noteworthy, as previous studies suggest that virus-induced LAC typically resolves within two to three months. Further research is needed to elucidate the long-term dynamics of LAC in post-COVID-19 condition patients and its clinical implications, particularly in relation to thrombotic complications associated with COVID-19.
Concepts | Keywords |
---|---|
Beta2 | antiphospholipid antibody |
Cardiolipin | covid-19 |
Fatigue | lupus anti-coagulant |
Japanese | post-covid-19 conditions (pcc) |
Months |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Sequelae |
disease | MESH | COVID-19 |
disease | IDO | history |
disease | MESH | atrial fibrillation |
disease | MESH | numbness |
drug | DRUGBANK | Cardiolipin |
drug | DRUGBANK | Factor IX Complex (Human) |